Cargando…
Leishmania donovani Develops Resistance to Drug Combinations
Drug combinations for the treatment of leishmaniasis represent a promising and challenging chemotherapeutic strategy that has recently been implemented in different endemic areas. However, the vast majority of studies undertaken to date have ignored the potential risk that Leishmania parasites could...
Autores principales: | García-Hernández, Raquel, Manzano, José Ignacio, Castanys, Santiago, Gamarro, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527373/ https://www.ncbi.nlm.nih.gov/pubmed/23285310 http://dx.doi.org/10.1371/journal.pntd.0001974 |
Ejemplares similares
-
Fitness of Leishmania donovani Parasites Resistant to Drug Combinations
por: García-Hernández, Raquel, et al.
Publicado: (2015) -
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
por: Rastrojo, Alberto, et al.
Publicado: (2018) -
Disruption of the Lipid-Transporting LdMT-LdRos3 Complex in Leishmania donovani Affects Membrane Lipid Asymmetry but Not Host Cell Invasion
por: Weingärtner, Adrien, et al.
Publicado: (2010) -
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
por: Gómez Pérez, Verónica, et al.
Publicado: (2016) -
Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy
por: Manzano, José Ignacio, et al.
Publicado: (2017)